Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Doses of histamine-2-receptor antagonists should be reduced in patients with low glomerular filtration rate

Nature Clinical Practice Nephrology volume 2, pages 298–299 (2006)Cite this article

boxed-textManlucu J et al. (2005) Dose-reducing H2 receptor antagonists in the presence of low glomerular filtration rate: a systematic review of the evidence. Nephrol Dial Transplant 20: 2376–2384

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Aronoff GR et al. (1999) Drug Prescribing in Renal Failure: Dosing Guidelines for Adults, edn 4. Philadelphia: American College of Physicians

    Google Scholar 

  2. Odeh M and Oliven A (1998) Central nervous system reactions associated with famotidine: report of five cases. J Clin Gastroenterol 27: 253–254

    CAS  PubMed  Google Scholar 

  3. Rodgers PT and Brengel GR (1998) Famotidine-associated mental status changes. Pharmacotherapy 18: 404–407

    CAS  PubMed  Google Scholar 

  4. Yoshimoto K et al. (1994) Famotidine associated central nervous system reactions and plasma and cerebrospinal drug concentrations in neurosurgical patients with renal failure. Clin Pharmacol Ther 55: 693–700

    CAS  PubMed  Google Scholar 

  5. Catalano G et al. (1996) Famotidine-associated delerium: a series of six cases. Psychosomatics 37: 349–355

    CAS  PubMed  Google Scholar 

  6. Redmond AM et al. (2005) Use of famotidine in adult patients with end-stage renal disease: assessment of dosing and mental status changes. Am J Med Sci 330: 8–10

    PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Dean for Clinical Research and Public Policy and Professor of Pharmacy and Medicine at Virginia Commonwealth University, Richmond, VA, USA

    Gary R Matzke

Authors
  1. Gary R Matzke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gary R Matzke.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matzke, G. Doses of histamine-2-receptor antagonists should be reduced in patients with low glomerular filtration rate. Nat Rev Nephrol 2, 298–299 (2006). https://doi.org/10.1038/ncpneph0182

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0182

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing